Han Yu Pharmaceutical (300199.SZ) plans to launch a restricted stock incentive plan in 2026.

Zhicheng Finance and Economics APP news, Hanyu Pharmaceuticals (300199.SZ) announced its 2026 restricted stock incentive plan (draft), planning to grant no more than 19.5 million restricted stocks to incentive targets, accounting for approximately 2.21% of the total capital of the company at the time of the announcement of this incentive plan draft. Among them, 17.35 million stocks will be granted for the first time, with no more than 111 incentive targets for the first grant, and the grant price is 11.61 yuan per share.